{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:07:54Z","timestamp":1775714874736,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2004,3,24]],"date-time":"2004-03-24T00:00:00Z","timestamp":1080086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1038\/sj.npp.1300442","type":"journal-article","created":{"date-parts":[[2004,3,24]],"date-time":"2004-03-24T05:27:14Z","timestamp":1080106034000},"page":"1270-1281","source":"Crossref","is-referenced-by-count":86,"title":["Behavioral and Neurochemical Consequences of Long-Term Intravenous Self-Administration of MDMA and Its Enantiomers by Rhesus Monkeys"],"prefix":"10.1038","volume":"29","author":[{"given":"William E","family":"Fantegrossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L","family":"Woolverton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kilbourn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Hatzidimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A","family":"Ricaurte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Winger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,3,24]]},"reference":[{"key":"BF1300442_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0892-0362(93)90067-X","volume":"15","author":"SF Ali","year":"1993","unstructured":"Ali SF, Newport GD, Scallet AC, Binienda Z, Ferguson SA, Bailey JR et al (1993). Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate. Neurotoxicol Teratol 15: 91\u201396.","journal-title":"Neurotoxicol Teratol"},{"key":"BF1300442_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02246943","volume":"110","author":"NA Ator","year":"1992","unstructured":"Ator NA, Griffiths RR (1992). Differential sensitivity to midazolam discriminative-stimulus effects following self-administered versus response-independent midazolam. Psychopharmacology 110: 1\u20134.","journal-title":"Psychopharmacology"},{"key":"BF1300442_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0091-3057(88)90155-4","volume":"29","author":"G Battaglia","year":"1988","unstructured":"Battaglia G, Yeh SY, DeSouza EB (1988). MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29: 269\u2013274.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300442_CR4","volume-title":"Pursuit of Ecstasy: The MDMA Experience","author":"J Beck","year":"1994","unstructured":"Beck J, Rosenbaum M (1994). Pursuit of Ecstasy: The MDMA Experience. State University of New York Press: Albany."},{"key":"BF1300442_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0161-813X(03)00030-5","volume":"24","author":"JF Bowyer","year":"2003","unstructured":"Bowyer JF, Young JF, Slikker W, Itzak Y, Mayorga AJ, Newport GD et al (2003). Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations. NeuroToxicology 24: 379\u2013390.","journal-title":"NeuroToxicology"},{"key":"BF1300442_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1476-5381.1993.tb12846.x","volume":"108","author":"MI Colado","year":"1993","unstructured":"Colado MI, Murray TK, Green AR (1993). 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine, and fenfluramine administration and effects of chlormethiazole and dizocilpine. Br J Pharmacol 108: 583\u2013589.","journal-title":"Br J Pharmacol"},{"key":"BF1300442_CR7","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1046\/j.1360-0443.2002.00222.x","volume":"97","author":"JC Cole","year":"2002","unstructured":"Cole JC, Bailey M, Sumnall HR, Wagstaff GF, King LA (2002). The content of ecstasy tablets: implications for the study of their long-term effects. Addiction 97: 1531\u20131536.","journal-title":"Addiction"},{"key":"BF1300442_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/syn.890140205","volume":"14","author":"JN DaSilva","year":"1993","unstructured":"DaSilva JN, Kilbourn MR, Domino EF (1993). In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazine. Synapse 14: 128\u2013131.","journal-title":"Synapse"},{"key":"BF1300442_CR9","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1749-6632.1990.tb16918.x","volume":"600","author":"EB DeSouza","year":"1990","unstructured":"DeSouza EB, Battaglia G, Insel TR (1990). Neurotoxic effects of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies. Ann NY Acad Sci 600: 682\u2013698.","journal-title":"Ann NY Acad Sci"},{"key":"BF1300442_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/BF02246100","volume":"117","author":"SI Dworkin","year":"1995","unstructured":"Dworkin SI, Mirkis S, Smith JE (1995). Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug. Psychopharmacology 117: 262\u2013266.","journal-title":"Psychopharmacology"},{"key":"BF1300442_CR11","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00213-002-1021-6","volume":"161","author":"WE Fantegrossi","year":"2002","unstructured":"Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G (2002). 3,4-methylenedioxy-methamphetamine (MDMA, \u2018Ecstasy\u2019) and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology 161: 356\u2013364.","journal-title":"Psychopharmacology"},{"key":"BF1300442_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1749-6632.1998.tb08233.x","volume":"844","author":"DL Frederick","year":"1998","unstructured":"Frederick DL, Ali SF, Gillam MP, Gossett J, Slikker W, Paule MG (1998). Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment. Ann NY Acad Sci 844: 183\u2013190.","journal-title":"Ann NY Acad Sci"},{"key":"BF1300442_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0892-0362(95)00013-H","volume":"17","author":"DL Frederick","year":"1995","unstructured":"Frederick DL, Ali SF, Slikker Jr W, Gillam MP, Allen RR, Paule MG (1995). Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Neurotoxicol Teratol 17: 531\u2013543.","journal-title":"Neurotoxicol Teratol"},{"key":"BF1300442_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.410400609","volume":"40","author":"K Frey","year":"1996","unstructured":"Frey K, Koeppe R, Kilbourne M, Vander Borght T, Albin R, Gilman S et al (1996). Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol 40: 873\u2013884.","journal-title":"Ann Neurol"},{"key":"BF1300442_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0014-2999(97)01152-7","volume":"334","author":"K Frey","year":"1997","unstructured":"Frey K, Kilbourne M, Robinson T (1997). Reduced striatal vesicular monoamine transporter after neurotoxic but not after behaviourally-sensitizing doses of methamphetamine. Eur J Pharmacol 334: 273\u2013279.","journal-title":"Eur J Pharmacol"},{"key":"BF1300442_CR16","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1124\/jpet.300.3.1093","volume":"300","author":"JP Hansen","year":"2002","unstructured":"Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR et al (2002). Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity. J Pharmacol Exp Ther 300: 1093\u20131100.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300442_CR17","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1523\/JNEUROSCI.19-12-05096.1999","volume":"19","author":"G Hatzidimitriou","year":"1999","unstructured":"Hatzidimitriou G, McCann U, Ricaurte G (1999). Altered serotonin innervation patterns in the forebrain of monkeys treated with (+\/\u2212)-3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19: 5096\u20135107.","journal-title":"J Neurosci"},{"key":"BF1300442_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s002130050365","volume":"133","author":"SE Hemby","year":"1997","unstructured":"Hemby SE, Co C, Koves TR, Smith JE, Dworkin SI (1997). Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology 133: 7\u201316.","journal-title":"Psychopharmacology"},{"key":"BF1300442_CR19","first-page":"197","volume":"24","author":"DM Jewett","year":"1997","unstructured":"Jewett DM, Kilbourn MR, Lee LC (1997). A simple synthesis of [11C]dihydrotetrabenazine. Appl Rad Isot 24: 197\u2013199.","journal-title":"Appl Rad Isot"},{"key":"BF1300442_CR20","unstructured":"Kirsch MM (1996). Ecstasy. Designer Drugs. CompCare Publications: Minneapolis (Minn). pp 75\u201397."},{"key":"BF1300442_CR21","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0091-3057(01)00708-0","volume":"71","author":"SJ Kish","year":"2002","unstructured":"Kish SJ (2002). How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacol Biochem Behav 71: 845\u2013855.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300442_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0006-8993(89)90700-2","volume":"488","author":"MS Kleven","year":"1989","unstructured":"Kleven MS, Woolverton WL, Seiden LS (1989). Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Brain Res 488: 121\u2013125.","journal-title":"Brain Res"},{"key":"BF1300442_CR23","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/00004647-199709000-00001","volume":"17","author":"RA Koeppe","year":"1997","unstructured":"Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE (1997). Equilibrium versus compartmentalized analysis for assessment of the vesicular monoamine transporter using (+)-\u03b1-[11C]dihydrotetrabenazine (DTBZ) and PET. J Cerebral Blood Flow Metab 17: 919\u2013931.","journal-title":"J Cerebral Blood Flow Metab"},{"key":"BF1300442_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/0091-3057(91)90129-P","volume":"39","author":"LE Markert","year":"1991","unstructured":"Markert LE, Roberts DS (1991). 3,4-methylenedioxyamphetamine (MDA) self-administration and neurotoxicity. Pharmacol Biochem Behav 39: 569\u2013574.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300442_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s002130100900","volume":"159","author":"AO Mechan","year":"2002","unstructured":"Mechan AO, Moran PM, Elliott M, Young AJ, Joseph MH, Green R (2002). A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; \u2018ecstasy\u2019) on the subsequent long-term behaviour of rats in the plus maze and open field. Psychopharmacology 159: 167\u2013175.","journal-title":"Psychopharmacology"},{"key":"BF1300442_CR26","first-page":"a15","volume":"14","author":"R Milani","year":"2000","unstructured":"Milani R, Turner JJD, Parrot AC, Parmar R (2000). Recreational drug use and psychobiological problems, collaborative UK\/Italy study (5): ecstasy (MDMA) polydrug findings. J Psychopharmacol 14: a15.","journal-title":"J Psychopharmacol"},{"key":"BF1300442_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF02740694","volume":"11","author":"D Miller","year":"1995","unstructured":"Miller D, O'Callaghan J (1995). The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine. Mol Neurobiol 11: 177\u2013192.","journal-title":"Mol Neurobiol"},{"key":"BF1300442_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s002130000545","volume":"152","author":"MJ Morgan","year":"2000","unstructured":"Morgan MJ (2000). Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 152: 230\u2013248.","journal-title":"Psychopharmacology"},{"key":"BF1300442_CR29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0028-3908(98)00029-X","volume":"37","author":"E O'Shea","year":"1998","unstructured":"O'Shea E, Granados R, Esteban B, Colado MI, Green AR (1998). The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (\u2018Ecstasy\u2019). Neuropharmacology 37: 919\u2013926.","journal-title":"Neuropharmacology"},{"key":"BF1300442_CR30","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1046\/j.1360-0443.1999.941116957.x","volume":"94","author":"W Pederson","year":"1999","unstructured":"Pederson W, Skrondal A (1999). Ecstasy and new patterns of drug use: a normal population study. Addiction 94: 1695\u20131706.","journal-title":"Addiction"},{"key":"BF1300442_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0006-8993(88)91309-1","volume":"446","author":"GA Ricaurte","year":"1988","unstructured":"Ricaurte GA, DeLanney LE, Irwin I, Langston JW (1988). Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res 446: 165\u2013168.","journal-title":"Brain Res"},{"key":"BF1300442_CR32","first-page":"616","volume":"261","author":"G Ricaurte","year":"1992","unstructured":"Ricaurte G, Martello A, Katz J, Martello M (1992). Lasting effects of (+\/\u2212)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther 261: 616\u2013622.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300442_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000026664","volume":"42","author":"GA Ricaurte","year":"2000","unstructured":"Ricaurte GA, Yuan J, McCann UD (2000). Methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42: 5\u201310.","journal-title":"Neuropsychobiology"},{"key":"BF1300442_CR34","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1126\/science.1074501","volume":"297","author":"GA Ricaurte","year":"2002","unstructured":"Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD (2002). Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA (\u2018Ecstasy\u2019). Science 297: 2260\u20132263.","journal-title":"Science"},{"key":"BF1300442_CR35","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1126\/science.301.5639.1479b","volume":"301","author":"GA Ricaurte","year":"2003","unstructured":"Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD (2003). Retraction. Science 301: 1479 (letter).","journal-title":"Science"},{"key":"BF1300442_CR36","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1124\/jpet.102.045005","volume":"304","author":"V Sandoval","year":"2003","unstructured":"Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE (2003). Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits. J Pharmacol Exper Ther 304: 1181\u20131187.","journal-title":"J Pharmacol Exper Ther"},{"key":"BF1300442_CR37","unstructured":"Saunders N (1995). Ecstasy and the Dance Culture. Neal's Yard Desktop Publishing: London."},{"key":"BF1300442_CR38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/0091-3057(91)90010-Y","volume":"38","author":"MD Schechter","year":"1991","unstructured":"Schechter MD (1991). Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination. Pharmacology, Biochemistry & Behavior 38: 539\u2013544.","journal-title":"Pharmacology, Biochemistry & Behavior"},{"key":"BF1300442_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0376-8716(98)00051-9","volume":"52","author":"F Schifano","year":"1998","unstructured":"Schifano F, DiFuria L, Forza G, Minicuci N, Bricolo R (1998). MDMA (\u2018ecstasy\u2019) consumption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend 52: 85\u201390.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300442_CR40","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1749-6632.1990.tb16917.x","volume":"600","author":"CJ Schmidt","year":"1990","unstructured":"Schmidt CJ, Kehne JH (1990). Neurotoxicity of MDMA: neurochemical effects. Ann NY Acad Sci 600: 665\u2013681.","journal-title":"Ann NY Acad Sci"},{"key":"BF1300442_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0376-8716(76)90030-2","volume":"1","author":"LS Seiden","year":"1976","unstructured":"Seiden LS, Fischman MW, Schuster CR (1976). Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend 1: 215\u2013219.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300442_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1192\/bjp.175.1.63","volume":"175","author":"DM Semple","year":"1999","unstructured":"Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC (1999). Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (\u2018ecstasy\u2019) users. Br J Psychiatry 175: 63\u201369.","journal-title":"Br J Psychiatry"},{"key":"BF1300442_CR43","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/emj.16.3.194","volume":"16","author":"K Sherlock","year":"1999","unstructured":"Sherlock K, Wolff K, Hay AW, Conner M (1999). Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department. J Accid Emerg Med 16: 194\u2013197.","journal-title":"J Accid Emerg Med"},{"key":"BF1300442_CR44","volume-title":"The Psychopharmacology of Addiction","author":"S Siegel","year":"1988","unstructured":"Siegel S (1988). Drug anticipation and drug tolerance. In Lader M (ed). The Psychopharmacology of Addiction. Oxford University Press: New York."},{"key":"BF1300442_CR45","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/0041-008X(88)90285-2","volume":"94","author":"W Slikker Jr","year":"1988","unstructured":"Slikker Jr W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR (1988). Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Toxicol Appl Pharmacol 94: 448\u2013457.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BF1300442_CR46","first-page":"529","volume":"10","author":"W Slikker Jr","year":"1989","unstructured":"Slikker Jr W, Holson RR, Ali SF, Kolta MG, Paule MG, Scallet AC et al (1989). Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Neurotoxicology 10: 529\u2013542.","journal-title":"Neurotoxicology"},{"key":"BF1300442_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0014-2999(99)00094-1","volume":"371","author":"R Stefanski","year":"1999","unstructured":"Stefanski R, Ladenheim B, Lee SH, Cadet JL, Goldberg SR (1999). Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur J Pharmacol 371: 123\u2013135.","journal-title":"Eur J Pharmacol"},{"key":"BF1300442_CR48","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/S0893-133X(02)00380-9","volume":"27","author":"MA Taffe","year":"2002","unstructured":"Taffe MA, Davis SA, Yuan J, Schroeder R, Hatzidimitriou G, Parsons LH et al (2002). Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge. Neuropsychopharmacology 27: 993\u20131005.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300442_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0014-2999(95)00594-3","volume":"294","author":"TM Vander Borght","year":"1995","unstructured":"Vander Borght TM, Kilbourn MR, Desmond TJ, Kuhl DE, Frey KA (1995). The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Eur J Pharmacol 294: 577\u2013583.","journal-title":"Eur J Pharmacol"},{"key":"BF1300442_CR50","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1523\/JNEUROSCI.18-01-00419.1998","volume":"18","author":"V Villemagne","year":"1998","unstructured":"Villemagne V, Yuan J, Wong DF, Dannals RF, Hatzidimitriou G, Mathews WB et al (1998). Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 18: 419\u2013427.","journal-title":"J Neurosci"},{"key":"BF1300442_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/00008877-199903000-00008","volume":"10","author":"TB Virden","year":"1999","unstructured":"Virden TB, Baker LE (1999). Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (+\/\u2212)-MDMA neurotoxicity: protection by fluoxetine. Behav Pharmacol 10: 195\u2013204.","journal-title":"Behav Pharmacol"},{"key":"BF1300442_CR52","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0893-133X(00)00170-6","volume":"24","author":"FX Vollenweider","year":"2001","unstructured":"Vollenweider FX, Jones RT, Baggott MJ (2001). Caveat Emptor: editors beware (reply). Neuropsychopharmacology 24: 461\u2013463.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300442_CR53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0376-8716(01)00195-8","volume":"66","author":"K von Sydow","year":"2002","unstructured":"von Sydow K, Lieb R, Pfister H, Hofler M, Wittchen HU (2002). Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults\u2014a transient phenomenon? Results from a longitudinal community study. Drug Alcohol Depend 66: 147\u2013159.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300442_CR54","first-page":"212","volume":"254","author":"JT Winslow","year":"1992","unstructured":"Winslow JT, Insel TR (1992). Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine (MDMA). J Pharmacol Exp Ther 254: 212\u2013220.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300442_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0376-8716(00)00215-5","volume":"64","author":"AR Winstock","year":"2001","unstructured":"Winstock AR, Griffiths P, Stewart D (2001). Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend 64: 9\u201317.","journal-title":"Drug Alcohol Depend"},{"key":"BF1300442_CR56","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S0140-6736(95)91774-8","volume":"346","author":"K Wolf","year":"1995","unstructured":"Wolf K, Hay AWM, Sherlock K, Conner M (1995). Contents of \u2018ecstasy\u2019. Lancet 346: 1100\u20131101.","journal-title":"Lancet"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300442","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T02:46:18Z","timestamp":1684205178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,24]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["BF1300442"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300442","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1019954.227437","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,24]]}}}